Correction: A systems pharmacology approach to determine active compounds and action mechanisms of xipayi kuijie'an enema for treatment of ulcerative colitis (Scientific Reports (2017) DOI: 10.1038/s41598-017-01335-w);A Systems Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Xipayi KuiJie'an enema for Treatment of Ulcerative colitis

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Yu, Wei ^a   Li, Zhihong ^c   Long, Fei ^a   Chen, Wen ^a   Geng, Yurong ^a   Xie, Zhiyong ^a   Yao, Meicun ^b   Han, Bo ^a   Liu, Teigang ^c  

^a SHIHEZI UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Dongzhimen Hospital of Beijing University of Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENEMA; IMMUNOLOGIC FACTOR; PLANT EXTRACT; TANNIN DERIVATIVE;

ANIMAL; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; OAK; PARASITOLOGY; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; ULCERATIVE COLITIS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS, ULCERATIVE; ENEMA; IMMUNOLOGIC FACTORS; MALE; MICE; PLANT EXTRACTS; QUERCUS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; TANNINS;

EID: 85018962296     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-21978-7     Document Type: Erratum

References (51)

1. Tanaka, T. Development of an Inflammation-Associated Colorectal Cancer Model and Its Application for Research on Carcinogenesis and Chemoprevention. International Journal of Inflammation 2012, 1144-1149 (2011).
2. Lombardi, V. R. M., Etcheverría, I., Carrera, I., Cacabelos, R. & Chacón, A. R. Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91. Biomed Research International 2012, 826178-826178 (2012).
3. Sclano, G. Asthma, nasal polyposis and ulcerative colitis: a new perspective. Clinical & Experimental Allergy Journal of the British Society for Allergy & Clinical Immunology 32, 1144-1149 (2002).
4. Fang, J. et al. Protection from inflammatory bowel disease and colitis-associated carcinogenesis with 4-vinyl-2,6-dimethoxyphenol (canolol) involves suppression of oxidative stress and inflammatory cytokines. Carcinogenesis 34, 2833-2841, doi: 10.1093/carcin/bgt309 (2013).
5. Yunusi, K. et al. Uygur Medicine Xipayi Kui Jie'an Affects Gene Expression profiles in intestinal tissue Lesions in a Rat Model of Ulcerative Colitis. Bmc Complementary & Alternative Medicine 15, 1-8 (2015).
6. Committee CP. Drug Standards of the Ministry of Public Health of thePeople's Republic of China. In: Book Drug Standards of the Ministry ofPublic Health of the People's Republic of China. City: Uygur PharmaceuticalSection (1998).
7. Aivazi, A. A. & Vijayan, V. A. Larvicidal activity of oak Quercus infectoria Oliv. (Fagaceae) gall extracts against Anopheles stephensi Liston. Parasitology research 104, 1289-1293, doi: 10.1007/s00436-008-1325-5 (2009).
8. Guo Xia, Y. & Kerim, A. Effect of Uyghur compound Xipayi Kuijie'an on the ultrastructure of small intestinal epithelial cell in Rat Model of Ulcerative Colitis. Journal of Xinjiang Medical University 32, 893-895 (2009).
9. Iminjan, M., Yunus, K., Hizbilla, M., Hupur, H. & Li, Y. Experimental Study of Effects of Uygur Medicine Xipayi Kuijie'an on Colon Mucosa Apoptosis and the Mechanism of Treating Ulcerative Colitis. Keji Daobao/Science & Technology Review 29, 29-35 (2011).
10. Upur, H. et al. The histologic effects of the Uyghur medicine xipayi kuijiean on ulcerative colitis in rats. Journal of the Australian Traditional-Medicine Society 17, 219 (2011).
11. Huang, C. et al. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Briefings in Bioinformatics 15, 710-733, doi: 10.1093/bib/bbt035 (2013).
12. Li, B. et al. Systems pharmacology-based approach for dissecting the addition and subtraction theory of traditional Chinese medicine: An example using Xiao-Chaihu-Decoction and Da-Chaihu-Decoction. Computers in Biology & Medicine 53, 19-29, doi: 10.1016/j.compbiomed.2014.05.007 (2014).
13. Ru, J. et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Journal of cheminformatics 6, 1 (2014).
14. Pei, T. et al. Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. Journal of ethnopharmacology (2016).
15. Zheng, C. et al. A novel systems pharmacology platform to dissect action mechanisms of traditional Chinese medicines for bovine viral diarrhea disease. European Journal of Pharmaceutical Sciences (2016).
16. Ma, C., Wang, L. & Xie, X. Q. GPU accelerated chemical similarity calculation for compound library comparison. Journal of chemical information and modeling 51, 1521-1527, doi: 10.1021/ci1004948 (2011).
17. Yu, H. et al. A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. PLoS One 7, e37608, doi: 10.1371/journal.pone.0037608 (2012).
18. Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P.-L. & Ideker, T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27, 431-432, doi: 10.1093/bioinformatics/btq675 (2011).
19. Sha, T., Igaki, K., Yamasaki, M., Watanabe, T. & Tsuchimori, N. Establishment and validation of a new semi-chronic dextran sulfate sodium-induced model of colitis in mice. International immunopharmacology 15, 23-29, doi: 10.1016/j.intimp.2012.10.022 (2013).
20. Li, Y. et al. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Molecular Immunology 47, 2467-2474, doi: 10.1016/j.molimm.2010.06.007 (2010).
21. Nishizawa, M., Yamagishi, T., Nonaka, G. & Nishioka, I. ChemInform Abstract: tannins and related compounds. part 9. isolation and characterization of polygalloylglucoses from turkish galls (quercus infectoria). Tannins and related compounds. XII. Isolation and characterization of galloylglucoses from Paeoniae Radix and their effects on urea-nitrogen concentration in rat serum. Chemical & Pharmaceutical Bulletin 14, 2593-2600 (1983).
22. Hasmida, M. N., Nur Syukriah, A. R., Liza, M. S. & Mohd Azizi, C. Y. Effect of different extraction techniques on total phenolic content and antioxidant activity of Quercus infectoria galls. International Food Research Journal (2014).
23. Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C. & Sandborn, W. J. Ulcerative colitis. Lancet 380, 1606-1619, doi: 10.1016/S0140-6736(12)60150-0 (2012).
24. Shrestha, S. et al. Pharmacognostic studies of insect gall of Quercus infectoria Olivier (Fagaceae). Asian Pacific Journal of Tropical Biomedicine 4, 35-39, doi: 10.1016/S2221-1691(14)60205-7 (2014).
25. Dubuquoy, L. et al. PPARγ as a new therapeutic target in inflammatory bowel diseases. Gut 55, 1341-1349, doi: 10.1136/gut.2006.093484 (2006).
26. Jiang, C., Ting, A. T. & Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86, doi: 10.1038/35154 (1998).
27. Rousseaux, C. et al. The 5-aminosalicylic acid (5-ASA) anti-neoplastic effect in the intestine is mediated by PPARγ. Carcinogenesis bgt245 (2013).
28. Bertin, B., Dubuquoy, L., Colombel, J.-F. & Desreumaux, P. PPAR-gamma in ulcerative colitis: a novel target for intervention. Current drug targets 14, 1501-1507, doi: 10.2174/13894501113149990162 (2013).
29. Desreumaux, P. et al. Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator-Activated Receptor γ (Pparγ) Heterodimer A Basis for New Therapeutic Strategies. The Journal of experimental medicine 193, 827-838, doi: 10.1084/jem.193.7.827 (2001).
30. Rousseaux, C. et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ. The Journal of experimental medicine 201, 1205-1215, doi: 10.1084/jem.20041948 (2005).
31. Su, C. et al. In Cytokines and Cell Homeostasis in the Gastrointestinal Tract: Proceedings of the Falk Symposium 113 Held in Regensburg, Germany, 16-18 September, 1999. 13 (Kluwer Academic Publishers).
32. Feagan, B. G. & MacDonald, J. K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. The Cochrane Library (2012).
33. Lewis, J. D. et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology 134, 688-695, doi: 10.1053/j.gastro.2007.12.012 (2008).
34. Pedersen, G. & Brynskov, J. Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-γ activity. The American journal of gastroenterology 105, 1595-1603, doi: 10.1038/ajg.2009.749 (2010).
35. Roberts, P. J., Morgan, K., Miller, R., Hunter, J. O. & Middleton, S. J. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 48, 468-472, doi: 10.1136/gut.48.4.468 (2001).
36. Wang, D. & Dubois, R. N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29, 781-788, doi: 10.1038/onc.2009.421 (2009).
37. Rodríguez, M. et al. Polarization of the innate immune response by prostaglandin E2: a puzzle of receptors and signals. Molecular pharmacology 85, 187-197, doi: 10.1124/mol.113.089573 (2014).
38. Atreya, I., Atreya, R. & Neurath, M. NFκB in inflammatory bowel disease. Journal of internal medicine 263, 591-596, doi: 10.1111/j.1365-2796.2008.01953.x (2008).
39. Spehlmann, M. E. & Eckmann, L. Nuclear factor-kappa B in intestinal protection and destruction. Current opinion in gastroenterology 25, 92-99, doi: 10.1097/MOG.0b013e328324f857 (2009).
40. Wullaert, A., Bonnet, M. C. & Pasparakis, M. NF-κB in the regulation of epithelial homeostasis and inflammation. Cell research 21, 146-158, doi: 10.1038/cr.2010.175 (2011).
41. Ren, T. et al. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway. Scientific reports 5, 10.1038/srep09047 (2015).
42. Glauben, R., Sonnenberg, E., Wetzel, M., Mascagni, P. & Siegmund, B. Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo. Journal of Biological Chemistry 289, 6142-6151, doi: 10.1074/jbc.M113.517599 (2014).
43. Shi, F. et al. Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis. Clinical Immunology 145, 230-240, doi: 10.1016/j.clim.2012.09.001 (2012).
44. Singh, N. P. et al. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One 6, e23522, doi: 10.1371/journal.pone.0023522 (2011).
45. Malik, A., Sharma, D., St, C. J., Dybas, L. A. & Mansfield, L. S. Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity. Mucosal Immunology 7, 802-817, doi: 10.1038/mi.2013.97 (2013).
46. Owen, C. J. et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. Journal of Clinical Endocrinology & Metabolism 88, 6034-6039, doi: 10.1210/jc.2003-031080 (2003).
47. Chung, S. W. et al. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. Journal of Biological Chemistry 275, 32681-32687, doi: 10.1074/jbc.M002577200 (2000).
48. Hong, R., Pownall, H. J. & Lodish, H. F. Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB. Journal of Biological Chemistry 278, 28181-28192, doi: 10.1074/jbc.M303141200 (2003).
49. Dubuquoy, L. et al. Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology 124, 1265-1276, doi: 10.1016/S0016-5085(03)00271-3 (2003).
50. Kelly, D. et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nature Immunology 5, 104-112, doi: 10.1038/ni1018 (2004).
51. Lin, Y. et al. Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice. Clinical & Experimental Pharmacology & Physiology 42, 76-86, doi: 10.1111/1440-1681.12321 (2014).